The ASRA COAGS app has been updated with a universal code base and a fresh new look. This
subscription-based app is $6.99/annually or free with ASRA Pain Medicine membership. The app
transforms the American Society of Regional Anesthesia and Pain Medicine anticoagulation guidelines
for Regional Anesthesia and Interventional Pain Procedures into a quick and easy reference for your
practice. It provides rapid access to drug-specific summary information.
This version combines the most current recommendations from two separate publications:
1. The 2025 guidelines “Regional anesthesia in the patient receiving antithrombotic or
thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-
Based Guidelines (Fifth Edition)” published in Regional Anesthesia & Pain Medicine.
2. The 2018 Interventional Pain guidelines from the publication “Interventional Spine and Pain
Procedures in Patients on Antiplatelet and Anticoagulant Medications (Second Edition);
Guidelines From the American Society of Regional Anesthesia and Pain Medicine, the European
Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the
International Neuromodulation Society, the North American Neuromodulation Society, and the
World Institute of Pain” published in Regional Anesthesia & Pain Medicine.
The app provides direct access to both the regional guidelines and the pain guidelines, also allowing you
to choose a default and focus on your specific practice area.
Regional Guidelines:
1. Search for drugs by brand name or generic name.
2. Get recommendations based on the block type (e.g. neuraxial, peripheral, obstetric) and the
intervention type (e.g. placing a block or removing a catheter).
3. Access more detailed information by using the Information "i" button:
a. Mechanism of action for each drug.
b. Executive summary for each drug.
c. The full 2025 ASRA Pain Medicine regional guideline document.
Pain Guidelines:
1. Search for drugs by brand name or generic name. Or start your search by procedure.
2. Get recommendations for:
a. High, intermediate, and low risk procedures.
b. Modifiers for patients at higher bleeding risk.
c. Herbal medications.
d. Antidepressant medications.
e. When to restart medications after a procedure.
3. Access more detailed information for any drug by using the Information "i" button:
a. Mechanism of action for each drug.
b. Executive summary for each drug.
c. The full 2018 ASRA Pain Medicine interventional pain guideline document.
Members of ASRA Pain Medicine receive all society apps for free with their membership. To learn more
or to join, visit asra.com/membership. Non-members have access to the content with a low-cost annual
subscription.
App developer needs to remove version number from App name
BrilliantMed
iOS now puts all app names in the custom autocorrect dictionary on iPhone. When you install this ASRA Coags app, it appears as “Coags 2.1” in your app menu. As a result, any time you type the number “21” in any app, iOS will try to autocorrect it to “2.1” because it thinks you are trying to type the name of this app. Try it… you’ll see I’m correct. Deleting the Coags app is the only way to get iOS to stop changing the number “21” to 2.1 in autocorrect. I’ve contacted the app developer previously. They are stubborn and refuse to remove the version number from the app name in iOS despite this problem. The version number is irrelevant anyway since iOS has automatically updated apps since version 6 or 7 of iOS.I delete the app and reinstall it about once a month to get info from it, then immediately delete it again.
Patient safety? Subscription only.
Kypdurron5
ASRA has made a declaration by locking clinicians out of an app they already paid for until they now also pay a subscription fee: ASRA is a greedy, money-loving corporation that cares nothing about patient safety. Might as well re-brand as a subsidiary of United Healthcare. It costs next to nothing to publish an app that furthers patient safety; I made one myself as a resident. This bait-and-switch on paying customers, and locking patient safety information behind a subscription paywall is an absolute disgrace on the field of Anesthesiology; this only reinforces our patient’s worst ideas about us. Shame. Shame. Shame.
Paid subscription even after paying for “lifetime access” 👎
DD, MD
Predatory business practice for an organization as well regarded as ASRA to now mandate a yearly paid subscription for an app that many of us originally paid for lifetime access. Appreciate the update in guidelines, which I would’ve been happy to support, but changing to a subscription model is shady and does not tender good will in a user base who already paid for this app. After several years of good use, will be deleting this app and will not be renewing my ASRA membership and will be encouraging my colleagues to do the same.
Used to be good until they started charging
Blahghg
I paid for this app (one time fee) and now they are charging a yearly subscription fee to use it. This is a bait and switch and I feel like they are nickel and diming just because they can. It used to be the gold standard app for coagulation status for perioperative care but now I will look elsewhere. The content is fine, but the pay structure is ridiculous. People who already paid for the app now have to pay extra and are not grandfathered in. Will be using other resources instead of ASRA
New update 6.1
Version 6.1
The developer, American Society of Regional Anesthesia and Pain Medicine, indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy .
Data Not Collected
The developer does not collect any data from this app.
Privacy practices may vary, for example, based on the features you use or your age. Learn More
Accessibility
The developer has not yet indicated which accessibility features this app supports. Learn More
Information
Seller
American Society of Regional Anesthesia and Pain Medicine
